Fröhlich, Ann-Kathrin
Porthun, Jan
Talha, Khawaja M.
Lena, Alessia
Hadzibegovic, Sara
Wilkenshoff, Ursula
Sonntag, Frederike
Nikolski, Anja
Ramer, Luisa Valentina
Zeller, Tanja
Keller, Ulrich
Bullinger, Lars
Anker, Stefan D.
Haverkamp, Wilhelm
von Haehling, Stephan
Doehner, Wolfram
Rauch, Ursula
Skurk, Carsten
Cleland, John G. F.
Butler, Javed
Coats, Andrew J. S.
Landmesser, Ulf
Karakas, Mahir
Anker, Markus S. http://orcid.org/0000-0002-4406-8555
Funding for this research was provided by:
Deutsches Zentrum für Herz-Kreislaufforschung (81Z0710102)
Charité - Universitätsmedizin Berlin
Article History
Received: 13 December 2023
Accepted: 7 February 2024
First Online: 8 April 2024
Declarations
:
: Dr Wilkenshoff is supported by a Clinical Fellowship Grant from the Berlin Institute of Health; and has received speaker fees and/or contributions to congresses from Abbott, AstraZeneca, Bayer, Berlin Chemie, Bristol Myers Squibb, GE Healthcare, Pfizer, Philips, and Servier, all outside the submitted work.Dr Zeller has received support from the German Centre for Cardiovascular Research (FKZ 81Z1710101 and FKZ 81Z0710102).Dr Karakas is supported by a Clinician Scientist Professorship Grant from the Else Kroener-Fresenius-Foundation; and has received personal fees and grant support from Daiichi-Sankyo, Adrenomed, Sphingotec, and Vifor Pharma, all outside the submitted work, and is a part-time employee of 4TEEN4 Pharmaceuticals.Dr Keller has served on advisory boards for Roche, Janssen-Cilag, Celgene, Takeda, Bristol Myers Squibb, Gilead, Hexal, Pfizer, AstraZeneca, and Pentixapharm; has received clinical research support from Janssen-Cilag, Novartis, Takeda, Bristol Myers Squibb, Roche, and Pfizer; and has received travel support from Roche, Bristol Myers Squibb, Gilead, Takeda, Janssen-Cilag, and Celgene.Dr Bullinger has received honoraria from AbbVie, Amgen, Astellas, Bristol Myers Squibb, Celgene, Daiichi-Sankyo, Gilead, Hexal, Janssen, Jazz Pharmaceuticals, Menarini, Novartis, Pfizer, Roche, Sanofi, and Seattle Genetics; and has received research support from Bayer and Jazz Pharmaceuticals.Dr S. Anker has received grants and personal fees from Vifor and Abbott Vascular; and has received personal fees for consulting, trial committee work, and/or lectures from Actimed, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Bioventrix, Brahms, Cardiac Dimensions, Cardior, Cordio, CVRx, Edwards Lifesciences, Faraday, Impulse Dynamics, Janssen, Novartis, Occlutech, Pfizer, Respicardia, Servier, Vectorious, and V-Wave, all outside the submitted work; and is named co-inventor of 2 patent applications regarding MR-proANP (DE 102007010834 & DE 102007022367), but does not benefit personally from the related issued patents.Dr Butler has received personal fees/fees as consultant from Abbott, American Regent, Amgen, Applied Therapeutic, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Cardiac Dimension, Cardior, CVRx, Cytokinetics, Edwards, Element Science, Innolife, Impulse Dynamics, Imbria, Inventiva, Lexicon, Lilly, LivaNova, Janssen, Medtronics, Merck, Occlutech, Novartis, Novo Nordisk, Pfizer, Pharmacosmos, Pharmain, Roche, Sequana, SQ Innovation, and Vifor.Dr Coats has received honoraria and/or speaker fees from AstraZeneca, Boehringer Ingelheim, Menarini, Novartis, Servier, Vifor, Abbott, Actimed, Arena, Cardiac Dimensions, Corvia, CVRx, Enopace, ESN Cleer, Faraday, Impulse Dynamics, Respicardia, and Viatris.Dr Landmesser has received institutional research grants from Amgen, Bayer, and Novartis; and has received speaker or consulting honoraria from AstraZeneca, Bayer, Boehringer, Amgen, Sanofi, Novartis, and Novo Nordisk.Dr M. Anker has received personal fees from Servier, outside the submitted work.Dr Zeller is listed as co-inventor of an international patent on the use of a computing device to estimate the probability of myocardial infarction (International Publication Number WO2022043229A1). TZ is shareholder of the ART.EMIS GmbH Hamburg.Dr von Haehling has been paid a consultant for and/or received honoraria payments from AstraZeneca, Bayer, Boehringer Ingelheim, BRAHMS, Chugai, Grünenthal, Helsinn, Hexal, Novartis, Pharmacosmos, Respicardia, Roche, Servier, Sorin, and Vifor. He also reports research support from Amgen, AstraZeneca, Boehringer Ingelheim, Innovative Medicines Initiative (IMI), and the German Center for Cardiovascular Research (DZHK).Dr. Doehner reports consulting fees and speaker honoraria from Aimediq, Bayer, Boehringer Ingelheim, Boston Scientific, Cardiomatics, Lilly, Medtronic, and Vifor Pharma; travel support from Pharmacosmos; and research support to the Institute from EU (Horizon2020), German Ministry of Education and Research, German Center for Cardiovascular Research, Boehringer Ingelheim, and Vifor Pharma.Dr Cleland reports personal fees from Abbott, Amgen, Novartis, Medtronic, Idorsia,Servier, AstraZeneca, Biopeutics, Torrent, and Respicardia; grants and personalfees from Bayer, Bristol Myers Squibb, Pharmacosmos, Vifor, Johnson & Johnson, Myokardia, and Viscardia; and personal fees and non-financial support from Boehringer Ingelheim and NI Medical.All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.